$CRI

CARTERS INC

No enriched coverage for $CRI in the last 7 days.

No SEC Form 4 filings for $CRI in the last 30 days.

Med

Carter’s (NYSE: CRI) hires Sharon Price John as CEO and sets interim leadership pay

Carter's, Inc. (NYSE: CRI) announced the appointment of Sharon Price John as its new Chief Executive Officer and President, effective June 15, 2026. Richard F. Westenberger will serve as Interim CEO during the transition, while the company reaffirmed its first-quarter and full-year fiscal 2026 outlook. The filing details Ms. John's compensation package, including a base salary, annual bonus, significant equity awards, and a sign-on bonus, alongside Mr. Westenberger's interim pay.

Carters (CRI) director adds shares through deferred dividend credit

Carters Inc. director Hali Borenstein acquired an additional 13.2684 shares of company common stock through a deferred dividend credit as part of the director deferred compensation program. This transaction was not an open-market trade but a grant resulting from a dividend payment. Following this credit, Borenstein now directly holds 17,020.3251 shares of Carters common stock, as reported in a Form 4 filing.

Carter's, Inc. (NYSE:CRI) Given Consensus Recommendation of "Hold" by Analysts

Eight analysts covering Carter's, Inc. (NYSE:CRI) have given the stock a consensus "Hold" rating, with an average one-year target price of $35.83. Despite mixed individual ratings (three sell, two hold, two buy, one strong buy), several firms recently raised their price targets and upgraded ratings. The company recently exceeded Q4 earnings expectations, reporting $1.90 EPS against a $1.70 estimate and revenue of $925.5 million, and declared a quarterly dividend of $0.25.

News on $CRI